Cargando…

Reversal by Sugammadex

Detalles Bibliográficos
Autor principal:	Bajaj, Pramila
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Editorial-II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894491/ https://www.ncbi.nlm.nih.gov/pubmed/20640200

Ejemplares similares

Message from the Editor
por: Bajaj, Pramila
Publicado: (2009)

Antifibrinolytic Agents: Aprotinin, and Desmopressin
por: Bajaj, Pramila
Publicado: (2009)

Benefits and risks of sugammadex
por: Park, Jong-Yeon
Publicado: (2015)

Limited advantage of sugammadex reversal over the traditional neuromuscular reversal technique in terms of postoperative recovery of bowel function
por: Kim, Duk Kyung
Publicado: (2020)

Use of sugammadex in clinical practice
por: Park, Hee-Pyoung
Publicado: (2017)

Repeat dosing of rocuronium-sugammadex: unpredictable
por: Kim, Yoon-Hee
Publicado: (2014)

Sugammadex is effective in reversing rocuronium in the presence of antibiotics
por: Hudson, Mark E, et al.
Publicado: (2014)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Sugammadex: a turning point in our practice
por: Lee, Sangseok
Publicado: (2013)

Sugammadex: watch out for new side effects
por: Kim, Yoon-Hee
Publicado: (2016)

What is the Youngest age Appropriate for Outpatient Surgery?
por: Bajaj, Pramila
Publicado: (2009)

Liver-Assisting Devices
por: Bajaj, Pramila
Publicado: (2009)

Regional Anaesthesia in the Patient with Pre-Existing Neurological Dysfunction
por: Bajaj, Pramila
Publicado: (2009)

Need to have more Biomedical Journals with Impact Factor and importance of Publication Audit
por: Jawaid, Shaukat Ali
Publicado: (2019)

Challenges of tackling non COVID-19 emergencies during the unprecedent pandemic
por: Mukunya, David, et al.
Publicado: (2020)

Prebiotic potential of gum Arabic for gut health
por: Elnour, Ahmed A. M., et al.
Publicado: (2023)

Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex
por: Brull, Sorin J, et al.
Publicado: (2009)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

In the hour of Sugammadex
por: Chon, Jin Young
Publicado: (2013)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Influence of methylprednisolone on the reversal time of sugammadex: a randomized clinical trial
por: Kocaoğlu, Merve Hayriye, et al.
Publicado: (2020)

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
por: Choi, Shu Chung, et al.
Publicado: (2020)

The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015)

Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
por: Alsaeed, Abdulhamid, et al.
Publicado: (2017)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

Sugammadex in pediatric patients
por: Choi, Jae Moon, et al.
Publicado: (2022)

Sugammadex in Emergency Situations
por: Motamed, Cyrus
Publicado: (2023)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
por: Aouad, Marie T., et al.
Publicado: (2017)

Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
por: Kashiwai, Akihiro, et al.
Publicado: (2012)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects
por: Wu, Xinmin, et al.
Publicado: (2014)

Sugammadex, a Neuromuscular Blockade Reversal Agent, Causes Neuronal Apoptosis in Primary Cultures
por: Palanca, José M., et al.
Publicado: (2013)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Comparison of reversal and adverse effects of sugammadex and combination of — Anticholinergic-Anticholinesterase agents in pediatric patients
por: Özgün, Çiğdem, et al.
Publicado: (2014)

Prediction of Optimal Reversal Dose of Sugammadex after Rocuronium Administration in Adult Surgical Patients
por: Otomo, Shigeaki, et al.
Publicado: (2014)

Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017)

Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
por: Trifa, Mehdi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4k2vcn7d4gvm7eadqqch842h7n